Ledger.Open graph →
SEC Form D · filed September 21, 2023

LB PHARMACEUTICALS INC

Offering
$110.7M
Sold
$70.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

Andrew Vaino · New York, NYExecMarc Panoff · New York, NYExecRebecca Luse · New York, NYDirectorAnna Eramo · New York, NYExecRajul Jain · New York, NYDirectorRan Nussbaum · New York, NYDirectorRobert Ruffolo · New York, NYDirectorZachary Prensky · New York, NYExec · DirectorSimon Basseyn · New York, NYDirectorRebecca Luse · New York, NYDirectorDean Rosenberg · San Diego, CAExecVincenzo O. Laruffa · New York, NYExecRan Nussbaum · New York, NYDirectorAnna Eramo · New York, NYExecRajul Jain · New York, NYDirectorMPG Asset Management, LLC · Murphy, TXDirectorRei Goffer · Boston, MAExec · DirectorJohn F. Arrillaga Jr · New York, NYExec · DirectorThomas Fortin · New York, NYExecLynne L. Segall · Beverly Hills, CAExecAndrew Chomer · Garrison, NYDirectorAlex Ruggieri · Vancouver, British Columbia, CanadaDirectorRoger Richer · Vancouver, British Columbia, CanadaExecFrancis Macdonald · Vancouver, British Columbia, CanadaDirectorBhavik M. Patel · Miami, FLDirectorSimon Basseyn · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗